-
Mashup Score: 6
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 6
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1ERK Inhibition Does Not Enhance BEACON Regimen Efficacy in Untreated BRAF V600E–Mutated CRC - 3 month(s) ago
Aparna Parikh, MD, discusses key findings from the HERKULES-3 study and what the future of the BRAF-mutated mCRC treatment paradigm may look like.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1ERK Inhibition Does Not Enhance BEACON Regimen Efficacy in Untreated BRAF V600E–Mutated CRC - 3 month(s) ago
Aparna Parikh, MD, discusses key findings from the HERKULES-3 study and what the future of the BRAF-mutated mCRC treatment paradigm may look like.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1ERK Inhibition Does Not Enhance BEACON Regimen Efficacy in Untreated BRAF V600E–Mutated CRC - 4 month(s) ago
Aparna Parikh, MD, discusses key findings from the HERKULES-3 study and what the future of the BRAF-mutated mCRC treatment paradigm may look like.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
Treatment Personalization Is Poised to Define New Era of mCRC Therapy @KristinCiombor @mgfakih @marshalj23 @asco #ASCO24 #ASCO2024 #crcsm https://t.co/xrlbO8mq7g